by Andrew Maynard | Dec 1, 2014 | Risk, Science Communication, Toxicology
Products with the label “BPA-free” have become ubiquitous on store shelves in recent years. It’s a trend that has been driven by consumer concerns that the chemical bisphenol-A, or BPA, may be harmful at low doses. Yet a recent study suggests that...
by Andrew Maynard | Nov 29, 2014 | Vaccines
A few weeks ago I talked with Katie Wells at Michigan Radio about why some people are reluctant to get flu shots – myself included up to last year. The interview was rebroadcast on Marketplace this last week, and can be heard here: The prompt for the story was...
by Andrew Maynard | Nov 26, 2014 | Health
Two related news items caught my eye this morning: First, the World Health Organization International Agency for Research on Cancer (IARC) has just published a new study in The Lancet claiming that in 2012, between 3% – 6% of all cancers around the world were...
by Andrew Maynard | Nov 19, 2014 | Public Health, Risk
Vaping has come of age it seems – at least according to the Oxford Dictionaries. The word “vape”, which is synonymous with electronic cigarette use, has been selected as the Oxford Dictionaries Word of the Year 2014. So what is vaping, and what are...
by Andrew Maynard | Nov 18, 2014 | Nanotechnology
First published in Nature Nanotechnology, 5 March 2014. Nature Nanotechnology 9, 159–160 (2014) doi:10.1038/nnano.2014.43 [Link] Ten years after the publication of an influential report on the uncertainties in nanoscale science and engineering, are we in danger of...
